Literature DB >> 10974227

Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation.

J Ausma1, W A Coumans, H Duimel, G J Van der Vusse, M A Allessie, M Borgers.   

Abstract

OBJECTIVE: Prolonged atrial fibrillation (AF) results in (ultra)structural remodelling of atrial cardiomyocytes resembling alterations seen in ischemia-induced ventricular hibernation. The mechanisms underlying these changes are incompletely understood. In the present study we explored the hypothesis that a profound imbalance in energy status during chronic AF acts as a stimulus for structural remodelling. METHODS AND
RESULTS: The content of high energy-phosphates and related compounds together with a selected number of mitochondrial enzymes, known to be altered under ischemic conditions, were determined in tissue samples taken from atria of goats in sinus rhythm (SR) and after 1, 2, 4, 8 and 16 weeks of AF maintained by burst pacing. Atrial remodelling was quantified by counting the percentage of cells with >10% myolysis. During AF structural remodelling developed progressively, after 8 weeks about 40% of the atrial myocytes were affected. The concentration of adenine nucleotides and their degradation products did not change significantly during AF. Also the activity of mitochondrial cytochrome c oxidase activity was similar during AF and SR. Mitochondrial NADH-oxidase and proton-translocating ATPase activities were not induced by AF. The tissue content of phosphocreatine decreased during the first week by 60%, but completely recovered between 8 and 16 weeks of AF.
CONCLUSIONS: The analysis of adenine nucleotides during AF provided no indication for the development of severe atrial ischemia. This notion is supported by enzyme cytochemical findings. However, AF-induced atrial remodelling was associated with a transient lowering of phosphocreatine content, suggesting an increase in energy demand during the early phase of AF. The subsequent recovery of the phosphocreatine pool indicates restoration of the balance between energy demand and supply in chronically fibrillating atria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974227     DOI: 10.1016/s0008-6363(00)00139-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  22 in total

Review 1.  Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).

Authors:  Niels Voigt; Fleur Mason; Dierk Thomas
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-08

2.  Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery.

Authors:  Evelin Seppet; Margus Eimre; Nadezhda Peet; Kalju Paju; Ehte Orlova; Mati Ress; Sirje Kõvask; Andres Piirsoo; Valdur A Saks; Frank N Gellerich; Stephan Zierz; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation.

Authors:  Maryam Goudarzi; Mark M Ross; Weidong Zhou; Amy Van Meter; Jianghong Deng; Lisa M Martin; Chidima Martin; Lance Liotta; Emanuel Petricoin; Niv Ad
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

4.  Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism--a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia.

Authors:  Lorenz Schild; Alicja Bukowska; Andreas Gardemann; Pamela Polczyk; Gerburg Keilhoff; Michael Täger; Samuel C Dudley; Helmut U Klein; Andreas Goette; Uwe Lendeckel
Journal:  Biochim Biophys Acta       Date:  2006-04-19

5.  Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.

Authors:  Guang-Zhong Liu; Ting-Ting Hou; Yue Yuan; Peng-Zhou Hang; Jing-Jing Zhao; Li Sun; Guan-Qi Zhao; Jing Zhao; Jing-Mei Dong; Xiao-Bing Wang; Hang Shi; Yong-Wu Liu; Jing-Hua Zhou; Zeng-Xiang Dong; Yang Liu; Cheng-Chuang Zhan; Yue Li; Wei-Min Li
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

6.  β3-Adrenoceptor Impairs Mitochondrial Biogenesis and Energy Metabolism During Rapid Atrial Pacing-Induced Atrial Fibrillation.

Authors:  Jingmei Dong; Jingjing Zhao; Miaomiao Zhang; Guangzhong Liu; Xiaobing Wang; Yixi Liu; Ning Yang; Yongwu Liu; Guanqi Zhao; Jiayu Sun; Jingpu Tian; Cheping Cheng; Lin Wei; Yue Li; Weimin Li
Journal:  J Cardiovasc Pharmacol Ther       Date:  2015-06-30       Impact factor: 2.457

7.  Atrial remodeling and metabolic dysfunction in idiopathic isolated fibrotic atrial cardiomyopathy.

Authors:  Chang Cui; Xiaohong Jiang; Weizhu Ju; Jiaxian Wang; Daowu Wang; Zheng Sun; Minglong Chen
Journal:  Int J Cardiol       Date:  2018-04-26       Impact factor: 4.164

8.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 9.  Mechanisms of arrhythmias and conduction disorders in older adults.

Authors:  Mahek Mirza; Anton Strunets; Win-Kuang Shen; Arshad Jahangir
Journal:  Clin Geriatr Med       Date:  2012-11       Impact factor: 3.076

10.  Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.

Authors:  Lynette Pretorius; Xiao-Jun Du; Elizabeth A Woodcock; Helen Kiriazis; Ruby C Y Lin; Silvana Marasco; Robert L Medcalf; Ziqiu Ming; Geoffrey A Head; Joon Win Tan; Nelly Cemerlang; Junichi Sadoshima; Tetsuo Shioi; Seigo Izumo; Elena V Lukoshkova; Anthony M Dart; Garry L Jennings; Julie R McMullen
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.